China’s Sywei may use Great Stone Park as platform for producing coronavirus vaccine
<p> MINSK, May 5 - PrimePress. The administration and the Development Company of the China-Belarus Industrial Park Great Stone have discussed with the vaccine manufacturer, Shanghai Biotechnology Company Sywei, the possibility of organising production of a vaccine against coronavirus in the park, the park’s press service said. </p> <p> </p> <p> “The company’s new vaccine (Sywei), approved by China's National Administration of Medical Products, has already demonstrated high efficacy and safety. The company’s investment partner is China Merchants Group, a shareholder in the industrial park,” the press service said. </p> <p> </p> <p> At present, three vaccines are used to vaccinate the population against coronavirus in Belarus: the Russian combined vector vaccine Gam-KOVID-Vac (or Sputnik V), the Chinese vaccine against SARS-CoV-2 (another name Sinopharm), and Gam-KOVID-Vac vaccine produced by Belmedpreparaty RUE. End </p> <p> </p>
2021-05-06
Primepress
China’s Sywei may use Great Stone Park as platform for producing coronavirus vaccine
MINSK, May 5 - PrimePress. The administration and the Development Company of the China-Belarus Industrial Park Great Stone have discussed with the vaccine manufacturer, Shanghai Biotechnology Company Sywei, the possibility of organising production of a vaccine against coronavirus in the park, the park’s press service said.
“The company’s new vaccine (Sywei), approved by China's National Administration of Medical Products, has already demonstrated high efficacy and safety. The company’s investment partner is China Merchants Group, a shareholder in the industrial park,” the press service said.
At present, three vaccines are used to vaccinate the population against coronavirus in Belarus: the Russian combined vector vaccine Gam-KOVID-Vac (or Sputnik V), the Chinese vaccine against SARS-CoV-2 (another name Sinopharm), and Gam-KOVID-Vac vaccine produced by Belmedpreparaty RUE. End